XTLB
XTL Biopharmaceuticals Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$2.53
+1.20%Margins
Gross margin
26.4%
EBITDA margin
-175.4%
EBIT margin
-481.6%
Net margin
-227.7%
FCF margin
0.0%
-18.9%
Return on equity
-12.0%
Return on assets
-39.0%
Return on invested capital
0.05x
Asset turnover
$0.00
Cash from operations
$0.47
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025